BLOODY MARYS WICKED HAND SANITIZER- ethyl alcohol liquid United States - English - NLM (National Library of Medicine)

bloody marys wicked hand sanitizer- ethyl alcohol liquid

bobbie weiner enterprises, l.l.c. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic hand sanitizer to help reduce bacteria that potentially can cause disease. for use when soap and water are not available.

LINCO-SPECTIN PREMIX ANTIBIOTIC FOR SWINE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

linco-spectin premix antibiotic for swine

zoetis australia pty ltd - lincomycin as lincomycin hydrochloride; spectinomycin as spectinomycin sulfate - oral powder, pre-mix - lincomycin as lincomycin hydrochloride antibiotic active 22.0 g/kg; spectinomycin as spectinomycin sulfate antibiotic active 22.0 g/kg - nutrition & metabolism - pigs | boar | gilt | piglet | sow | swine - bloody scours | enteritis associated with e.coli | mycoplasmal pneumonia | promote animal growth | salmonellosis | vibrionic dysentery | feed conversion | finishing | growth promotion | growth rate | liveweight gain | swine dysentery

TAVANIC TABLETS 500 MG Israel - English - Ministry of Health

tavanic tablets 500 mg

sanofi israel ltd - levofloxacin as hemihydrate - film coated tablets - levofloxacin as hemihydrate 500 mg - levofloxacin - levofloxacin - tavanic tablets 500 mg is indicated in adults for the treatment of the following infections:- acute pyelonephritis and complicated urinary tract infections - chronic bacterial prostatitisin the below-mentioned infections, tavanic should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections.- acute bacterial sinusitis - acute exacerbations of chronic obstructive pulmonary disease including bronchitis - community-acquired pneumonia- complicated skin and soft tissue infections.tavanic may also be used to complete a course of therapy in patients who have shown improvement during initial treatment with intravenous levofloxacin.consideration should be given to official guidance on the appropriate use of antibacterial agents.

ZOMIG 2.5 MG Israel - English - Ministry of Health

zomig 2.5 mg

astrazeneca (israel) ltd - zolmitriptan - film coated tablets - zolmitriptan 2.5 mg - zolmitriptan - zolmitriptan - acute treatment of migraine with or without aura.

RIZALT 5 MG TABLETS Israel - English - Ministry of Health

rizalt 5 mg tablets

merck sharp & dohme israel ltd - rizatriptan as benzoate - tablets - rizatriptan as benzoate 5 mg - rizatriptan - rizatriptan - rizalt is indicated for the acute treatment of migraine attacks with or without aura in adults

RIZALT 10 MG TABLETS Israel - English - Ministry of Health

rizalt 10 mg tablets

organon pharma israel ltd., israel - rizatriptan as benzoate - tablets - rizatriptan as benzoate 10 mg - rizatriptan - rizatriptan - rizalt is indicated for the acute treatment of migraine attacks with or without aura in adults.

RIZALT  RPD 10 MG WAFERS Israel - English - Ministry of Health

rizalt rpd 10 mg wafers

organon pharma israel ltd., israel - rizatriptan as benzoate - tablets soluble in mouth - rizatriptan as benzoate 10 mg - rizatriptan - rizatriptan - rizalt is indicated for the acute treatment of migraine attacks with or without aura in adults.

RULID 150 MG Israel - English - Ministry of Health

rulid 150 mg

sanofi - aventis israel ltd - roxithromycin - film coated tablets - roxithromycin 150 mg - roxithromycin - for the treatment of infections caused by microorganisms sensitive to roxithromycin e.g: ent bronchopulmonary, genital and skin manifestations.

Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva European Union - English - EMA (European Medicines Agency)

efavirenz/emtricitabine/tenofovir disoproxil zentiva

zentiva k.s. - efavirenz, emtricitabine, tenofovir disoproxil, phosphate - hiv infections - antivirals for systemic use, - efavirenz/emtricitabine/tenofovir disoproxil zentiva is a fixed-dose combination of efavirenz, emtricitabine and tenofovir disoproxil. it is indicated for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adults aged 18 years and over with virologic suppression to hiv-1 rna levels of < 50 copies/ml on their current combination antiretroviral therapy for more than three months. patients must not have experienced virological failure on any prior antiretroviral therapy and must be known not to have harboured virus strains with mutations conferring significant resistance to any of the three components contained in efavirenz/emtricitabine/tenofovir disoproxil zentiva prior to initiation of their first antiretroviral treatment regimen., the demonstration of the benefit of the combination efavirenz/emtricitabine/tenofovir disoproxil is primarily based on 48-week data from a clinical study in which patients with stable virologic suppression on a combination antiretroviral therapy changed to efavir